Literature DB >> 25393126

Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD.

Amany F Elbehairy1, Natya Raghavan2, Sicheng Cheng3, Ling Yang1, Katherine A Webb3, J Alberto Neder3, Jordan A Guenette4, Mahmoud I Mahmoud5, Denis E O'Donnell3.   

Abstract

BACKGROUND: Smokers with persistent cough and sputum production (chronic bronchitis [CB]) represent a distinct clinical phenotype, consistently linked to negative clinical outcomes. However, the mechanistic link between physiologic impairment, dyspnea, and exercise intolerance in CB has not been studied, particularly in those with mild airway obstruction. We, therefore, compared physiologic abnormalities during rest and exercise in CB to those in patients without symptoms of mucus hypersecretion (non-CB) but with similar mild airway obstruction.
METHODS: Twenty patients with CB (≥ 3 months cough/sputum in 2 successive years), 20 patients without CB but with GOLD (Global Initiative for Chronic Obstructive Lung Disease) grade IB COPD, and 20 age- and sex-matched healthy control subjects underwent detailed physiologic testing, including tests of small airway function and a symptom-limited incremental cycle exercise test.
RESULTS: Patients with CB (mean ± SD postbronchodilator FEV1, 93% ± 12% predicted) had greater chronic activity-related dyspnea, poorer health-related quality of life, and reduced habitual physical activity compared with patients without CB and control subjects (all P < .05). The degree of peripheral airway dysfunction and pulmonary gas trapping was comparable in both patient groups. Peak oxygen uptake was similarly reduced in patients with CB and those without compared with control subjects (% predicted ± SD, 70 ± 26, 71 ± 29 and 106 ± 43, respectively), but those with CB had higher exertional dyspnea ratings and greater respiratory mechanical constraints at a standardized work rate than patients without CB (P < .05).
CONCLUSIONS: Patients with CB reported greater chronic dyspnea and activity restriction than patients without CB and with similar mild airway obstruction. The CB group had greater dynamic respiratory mechanical impairment and dyspnea during exercise than patients without CB, which may help explain some differences in important patient-centered outcomes between the groups.

Entities:  

Mesh:

Year:  2015        PMID: 25393126     DOI: 10.1378/chest.14-1491

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Classifying Chronic Lower Respiratory Disease Events in Epidemiologic Cohort Studies.

Authors:  Elizabeth C Oelsner; Laura R Loehr; Ashley G Henderson; Kathleen M Donohue; Paul L Enright; Ravi Kalhan; Christian M Lo Cascio; Andrew Ries; Neomi Shah; Benjamin M Smith; Wayne D Rosamond; R Graham Barr
Journal:  Ann Am Thorac Soc       Date:  2016-07

2.  Pilot evaluation of ivacaftor for chronic bronchitis.

Authors:  George M Solomon; Heather Hathorne; Bo Liu; S Vamsee Raju; Ginger Reeves; Edward P Acosta; Mark T Dransfield; Steven M Rowe
Journal:  Lancet Respir Med       Date:  2016-05-16       Impact factor: 30.700

3.  Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.

Authors:  Yusheng Cheng; Xiongwen Tu; Linlin Pan; Shuai Lu; Ming Xing; Linlin Li; Xingwu Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-18

Review 4.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

5.  The outcome and the influencing factors of the age of onset in post-mortem of chronic bronchitis patients: a retrospective study.

Authors:  Linyun Zhu; Zhenhua Ni; Xuming Luo; Zhuhua Zhang; Shiqiang Wang; Ziyu Meng; Xiandong Gu; Xiongbiao Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-21

6.  Nitrogen single-breath washout test for evaluating exercise tolerance and quality of life in patients with chronic obstructive pulmonary disease.

Authors:  C A L Deus; P S Vigário; F S Guimarães; A J Lopes
Journal:  Braz J Med Biol Res       Date:  2018-02-26       Impact factor: 2.590

7.  Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers.

Authors:  Raúl H Sansores; Mónica Velázquez-Uncal; Oliver Pérez-Bautista; Jaime Villalba-Caloca; Ramcés Falfán-Valencia; Alejandra Ramírez-Venegas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.